[RPRX] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[RPRX] Royalty Pharma plc
Announcement Date
31-Dec-2019
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- 70.46%
Quarter Report
RPRX's Result
RPRX's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 2,237,215 2,289,463 2,122,000 1,814,254 1,794,894 1,597,930 1,877,410 2.96%
PBT 230,064 1,241,201 1,702,000 2,461,419 1,517,855 1,343,180 761,895 -18.08%
Tax 187,232 762,447 1,147,000 349,333 433,365 542,655 195,988 -0.75%
NP 42,832 478,754 495,198 2,348,535 1,377,729 1,210,025 565,907 -34.94%
Tax Rate -81.38% -61.43% -67.39% -14.19% -28.55% -40.40% -25.72% -
Total Cost 2,194,383 1,810,709 1,626,802 -534,281 417,165 387,905 1,311,503 8.95%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin 1.91 20.91 23.34 129.45 76.76 75.72 30.14 -36.84%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS 0.10 1.15 1.32 6.42 3.89 3.42 0.93 -31.03%
EPS Diluted 0.10 1.15 1.32 6.42 3.89 3.42 0.93 -31.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.